Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods
      QxMD      Google Scholar   
Citation:
J. Clin. Oncol vol 33 (34) 4048-4057
Year:
2015
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
Yes
Biospecimen:
No
DataSharing:
No
Book Volume:
Parents:
394   674  
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA180821, CA167326, R21 CA167326, P30 CA015083, U10 CA180882  
Corr. Author:
 
Authors:
             
Primary Study
NCCTG-N9741
Secondary Studies:
Phases:
3
Keywords:
Bios3, ORIGINAL REPORTS, Clinical Trials